Medpace director exercises 29 RSUs into shares
Medpace Holdings director Cornelius P. McCarthy III exercised restricted stock units that converted into 29 shares of common stock on March 31, 2026.
Rhea-AI Filing Summary
Medpace Holdings director Cornelius P. McCarthy III exercised restricted stock units that converted into 29 shares of common stock on March 31, 2026. The award was part of a 113-unit grant from November 28, 2025 that vests in four approximately equal installments through December 31, 2026. Following this vesting event, he directly owns 10,324 shares of common stock and 84 restricted stock units, each representing a contingent right to receive one share of Medpace common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Unit | 29 | $0.00 | $0.00 |
| Exercise | Common Stock | 29 | $0.00 | $0.00 |
Footnotes (2)
- F1. Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.
- F2. On November 28, 2025, the Reporting Person was granted 113 restricted stock units vesting in four approximately equal installments on March 31, 2026, June 30, 2026, September 30, 2026 and December 31, 2026.
Key Figures
Key Terms
Restricted Stock Unit financial
derivative security financial
contingent right financial
vesting financial
exercise or conversion financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Medpace (MEDP) report for Cornelius P. McCarthy III?
What are the terms of the restricted stock unit grant reported by Medpace (MEDP)?
How many Medpace (MEDP) restricted stock units vested on March 31, 2026?
AI-generated analysis. How Rhea-AI works. Not financial advice.